ABVC BioPharma, Inc. Proceeds from Notes Payable
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Notes Payable of $1.35 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-11-15
- ABVC BioPharma, Inc. proceeds from notes payable for the quarter ending 2023-09-30 was -$1.82M.
- ABVC BioPharma, Inc. proceeds from notes payable for the quarter ending 2023-06-30 was -$31.59K.
- ABVC BioPharma, Inc. proceeds from notes payable for the quarter ending 2023-03-31 was $3.21M.
- ABVC BioPharma, Inc. proceeds from notes payable for fiscal 2015 was $0.00.
- ABVC BioPharma, Inc. proceeds from notes payable for fiscal 2014 was $0.00.
| Period end | Proceeds from Notes Payable 0 month | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | -$1.85M derived: sum of 2 quarters · filed 2023-11-15 | $1.35M 10-Q · filed 2023-11-15 | ||
| 2023-06-30 | -$31.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.17M 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $3.21M 10-Q · filed 2023-05-15 | ||||
| 2015-09-30 | $0.00 10-K · filed 2015-11-27 | ||||
| 2014-09-30 | $7.00K 10-K · filed 2015-11-27 | ||||
| 2014-09-18 | $0.00 10-K · filed 2015-11-27 |